SSA
WHWK

Schonfeld Strategic Advisors’s Whitehawk Therapeutics WHWK Stock Holding History

Schonfeld Strategic Advisors’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-41,600
Closed -$131K – 2570
2024
Q4 		$131K Sell
41,600
-100
-0.2% -$227 ﹤0.01% 1816
2024
Q3 		$85.9K Hold
41,700
– – ﹤0.01% 1876
2024
Q2 		$60.9K Hold
41,700
– – ﹤0.01% 1914
2024
Q1 		$97.6K Hold
41,700
– – ﹤0.01% 1851
2023
Q4 		$84.2K Buy
41,700
+2,700
+7% +$11.3K ﹤0.01% 1639
2023
Q3 		$189K Buy
39,000
+2,600
+7% +$15.1K ﹤0.01% 1422
2023
Q2 		$249K Sell
36,400
-8,900
-20% -$69.2K ﹤0.01% 1469
2023
Q1 		$328K Buy
45,300
+24,100
+114% +$257K ﹤0.01% 1331
2022
Q4 		$272K Sell
21,200
-56,200
-73% -$734K ﹤0.01% 1838
2022
Q3 		$320K Buy
+77,400
New +$1.02M ﹤0.01% 2038
2022
Q1 		– Sell
-15,800
Closed -$381K – 2980
2021
Q4 		$381K Buy
+15,800
New +$397K ﹤0.01% 1408
2021
Q3 		– Sell
-3,873
Closed -$98K – 2532
2021
Q2 		$98K Sell
3,873
-894
-19% -$20.4K ﹤0.01% 1828
2021
Q1 		$92K Buy
4,767
+3,974
+501% +$91.5K ﹤0.01% 1676
2020
Q4 		$12K Buy
+793
New +$17K ﹤0.01% 1523

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Schonfeld Strategic Advisors's WHWK Position: Q1 2025 in Review

Schonfeld Strategic Advisors sold out of Whitehawk Therapeutics (WHWK) in Q1 2025, closing a stake of 41,600 shares — an estimated $131K sold.

Schonfeld Strategic Advisors first reported a position in WHWK in Q4 2020 and held it in 14 quarters. The position peaked at $381K in Q4 2021. 50 funds tracked by Wall St. Rank hold WHWK as of Q1 2025.

  • Schonfeld Strategic Advisors reported no remaining Whitehawk Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 41,600 Whitehawk Therapeutics shares in Q1 2025, an estimated $131K.
  • Schonfeld Strategic Advisors first reported a position in Whitehawk Therapeutics in Q4 2020 and held it in 14 quarters.
  • Schonfeld Strategic Advisors's Whitehawk Therapeutics position peaked at $381K in Q4 2021.
  • 50 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2025, filed 15 May 2025.